RXST (RxSight) Institutional Ownership: 97.65% (As of Jul. 12, 2026)


RXST RxSight Inc RXST
68 GF Score
Price $4.95
GF Value $35.80
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is RxSight Institutional Ownership?

RxSight RXST -2.85% 68 Institutional Ownership is 97.65% as of Jul. 12, 2026. GuruFocus rates RXST with a GF Score™ of 68/100 and a GF Value™ of $35.80 (Possible Value Trap). The stock has 4 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, RxSight's institutional ownership is 97.65%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, RxSight's Insider Ownership is 3.78%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, RxSight's Float Percentage Of Total Shares Outstanding is 94.70%.

RxSight Institutional Ownership Historical Data

* Premium members only.

The historical data trend for RxSight's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RxSight Institutional Ownership Chart

RxSight Historical Data

The historical data trend for RxSight can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 28.55 28.51 29.64 31.54 30.55 31.07 34.35 34.30 33.97 35.14
RXST
68GF Score
RxSight Inc RXST
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RxSight Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 97.65% mean?
RxSight (RXST) has a Institutional Ownership of 97.65% as of Jul. 12, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on RxSight and its competitors.
Is RxSight's Institutional Ownership too high?
RxSight's current Institutional Ownership is 97.65%. Overall, RxSight has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does RxSight's Institutional Ownership compare to LUCD and QTRX?
RxSight's Institutional Ownership of 97.65% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Devices & Instruments company?
A good Institutional Ownership depends on the Medical Devices & Instruments industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on RxSight and its competitors. RxSight's current Institutional Ownership is 97.65%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RxSight stock overvalued right now?
Based on GuruFocus' analysis, RxSight (RXST) is currently considered Possible Value Trap. The stock's GF Value™ is $35.80, compared to a current price of $4.95 — trading 86.2% below its estimated fair value. The current Institutional Ownership is 97.65%. RxSight's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For RxSight (RXST), the current Institutional Ownership is 97.65% as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is RxSight (RXST) Overvalued in 2026?

Based on GuruFocus' analysis, RxSight stock appears to be undervalued. The current stock price of $4.95 is trading 86.2% below its estimated GF Value™ of $35.80. GuruFocus considers RxSight to be Possible Value Trap.

Key valuation signals for RXST:

  • Institutional Ownership: 97.65%
  • GF Value™: $35.80 vs. price of $4.95 (86.2% below fair value)
  • GF Score™: 68/100 with 4 warning signs

No single metric tells the full story. See the RXST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

RxSight Business Description

Address 100 Columbia, Aliso Viejo, CA, USA, 92656
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.
68GF Score

Get the complete analysis for RXST

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.95
Price
$35.80
GF Value